Petlife Pharmaceuticals, Inc.
PTLF
$0.0001
$0.000.00%
02/28/2018 | 11/30/2017 | 08/31/2017 | 05/31/2017 | 02/28/2017 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1,875.00% | 87.24% | 4,425.00% | -- | -- |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -96.30% | 98.62% | 4,483.33% | 279.17% | 4,345.83% |
|
|||||
Total Current Assets | -96.30% | 98.62% | 4,483.33% | 279.17% | 4,345.83% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | 41,916.67% | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -96.30% | 98.62% | 4,483.33% | 4,905.56% | 3,851.85% |
|
|||||
Total Accounts Payable | -19.77% | -27.95% | -50.20% | -47.86% | -28.82% |
Total Accrued Expenses | -18.91% | -35.70% | -- | -- | -- |
Short-term Debt | 99.58% | 102.30% | 368.76% | 8,349.00% | 3,917.00% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -84.24% | -95.17% | -- | -- |
Total Other Current Liabilities | -- | -84.24% | -95.17% | -- | -- |
Total Current Liabilities | 75.96% | -56.16% | -55.61% | 143.41% | 112.33% |
|
|||||
Total Current Liabilities | 75.96% | -56.16% | -55.61% | 143.41% | 112.33% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 99.58% | 102.30% | 368.76% | 8,349.00% | 3,917.00% |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 75.96% | -56.16% | -55.61% | 143.41% | 112.33% |
|
|||||
Common Stock & APIC | 9.92% | 31.57% | 644.35% | 756.51% | 743.69% |
Retained Earnings | -13.45% | -17.56% | -326.12% | -645.33% | -648.29% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -116.62% | 57.16% | 57.19% | -103.76% | -73.86% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -116.62% | 57.16% | 57.19% | -103.76% | -73.86% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -116.25% | 57.24% | 57.29% | -103.76% | -73.86% |
|